chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported that she felt dizzy, fell, and vomitted about 5 hours after vaccine administration when we was at home.  Vaccine as administered in the pharmacy around 1pm.   She was taken to the ER later at 7 or 8pm on same day flu shot was given.  Pt has no previous history of problems with flu vaccines in past and gets flu shots annually.
This spontaneous report was received from a nurse prescriber via a company representative and refers to a 18-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On an unspecified day in September 2018 (reported as within the last week), the patient was vaccinated concomitantly with GARDASIL 9 and hepatitis A vaccine (manufacturer unknown) (lot #, expiration date, dose, site and route of administration were not reported for both vaccines) for prophylaxis. On the same date (reported as ''at the time of injection''), the patient ''passed out''. It was reported, the patient recovered ''quickly'' from the event on an unspecified day in September 2018. The patient did not receive treatment for the event and did not seek medical attention. The causality assessment between the event and GARDASIL 9 and hepatitis A vaccine (manufacturer unknown) was not provided.
Pt reported on set of left upper quad sharp constant pain and vomiting approximately 1 hour post vax. Pt denies any other signs or symptoms.
Approx 2 mins after flu vaccine administered to left deltoid employee reports the following s/s: warm "rush," tightness in chest, diaphoresis, fever, anxiety, heart palpitations. She also reports prolonged adverse effects (3-4 days) of fever, diarrhea, nausea, and dizziness.
little bit of a fever 37.8; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 30Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced little bit of a fever 37.8 on an unspecified date with outcome of unknown.  Information on the lot/batch number has been requested.
it hit my nerve; My arm was sore all the way from shoulder to my fingers; My fingers were tingling when i go to bed and when i wake up in the morning; hurts in my arm; A spontaneous report was received from a healthcare professional concerning a 81-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events it hit my nerve, arm was sore all the way from shoulder to my fingers, fingers were tingling when i go to bed and when i wake up in the morning, hurts in my arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 29 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Lot# 012M20A) via unknown route in the right arm for prophylaxis of COVID-19 infection. On 26 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Lot# 014M20A) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient experienced the event(s) it hit my nerve, arm was sore all the way from shoulder to my fingers, fingers were tingling when i go to bed and when i wake up in the morning, hurts in my arm.  Treatment details included Aspirin, Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), it hit my nerve, arm was sore all the way from shoulder to my fingers, fingers were tingling when i go to bed and when i wake up in the morning, hurts in my arm was unknown.
Lump in left axilla. Pain to the touch. A little of fever and muscular pain, especially legs and feet.
Blotchy skin redness at injection site, malaise, muscle aches, vesicle on left arm over bicep and left lower leg below knee. Vesicle on left arm healed. One on left lower leg was evaluated by Dr. and treated with BACTRIM with resolution of cellulitis. MRSA positive.
This spontaneous report as received on 17-FEB-2017 from a registered nurse, which refers to unspecified patients (age and gender not reported). The patients' pertinent medical history, current conditions and concomitant medications were not reported. The registered nurse reported that some improperly stored doses of GARDASIL 9 (Lot number M034780, expiration date 15-APR-2019), PNEUMOVAX 23 (Lot number M038359, expiration date 13-MAY-2018) and PEDVAXHIB (Lot number M036612, expiration date 19-MAY-2019) were administered to unspecified patients on 15-FEB-2017 and 16-FEB-2017. No adverse effects reported. The vaccines were exposed to temperatures as reported: Temperature: between 32F and 36F for 6 hours 40 minutes, also below 32F for 20 minutes. Time frame: 7 hours. There were no previous excursions reported. The call was because of a data logger. No additional information was provided. Additional information has been requested.
Headache, Myalgia, Arthralgia, fatigue, injection site pain/arm pain, congestion Narrative:
Severe jaw pain; Pain brushing her teeth; Right side of her face hurt; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt). On 08-Mar-2021, PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
No refrigeration used/In one case the Shingrix vials were put in a pill bottle and mailed.; This case was reported by a nurse via sales rep and described the occurrence of intercepted product storage error in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient did not receive Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted product storage error. On an unknown date, the outcome of the intercepted product storage error was unknown.    Additional Information: GSK receipt date: 22-SEP-2022 Reporters comment:  The reporter reported that 4 patients that had a prescription sent to pharmacy the pharmacy mailed the Shingrix to their home for the patient to bring in office to be administered. These were patients. No refrigeration was used by pharmacy. In one case the Shingrix vials were put in a pill bottle and mailed.All doses were spoiled, and patients sent back to pharmacy.  The nurse was checking with patients to see if the patient had got the vaccination after that. The reporter agrees to follow up from GlaxoSmithKline. Additional Supportive Information: All doses were spoiled, and patient had not received the doses, which led to Intercepted product storage error. This case was 1 of 4 cases for the patient reported by same reporter; Sender's Comments:  US-GSK-US2022AMR136884:Same reporter- Patient 2 US-GSK-US2022AMR136885:Same reporter- Patient 3 US-GSK-US2022AMR136866:Same reporter- Patient 4
Patient received COVID-19 vaccine (Moderna)  on 5/14/2021.  Patient reports severe aching that at first seemed more generalized, but seems to have settled more in the abdomen and back.  Patient reports this is the most severe stomach/back pain she has ever experienced.  She reports not being able to hug another person due to discomfort.  Recommended patient seek prompt evaluation at urgent care as she reports symptoms appear to be worsening throughout the day.
Pt reported that she had eye swelling and was given Benadryl and Tylenol ATC. Pt was immunized at 17:00 and onset was 21:00 (4 hours total) and swelling lasted about 1 day, per father's report.
Patient's daughter, states her mother has had arm pain since the flu shot. Her mom went to her doctor who told her it was " Vaccine Shoulder"
This is a spontaneous report from a contactable pharmacist who reported for her daughter. A female patient of an unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at the paediatrician's office at single dose for immunization. The patient's medical history was not reported. The patient's concomitant medications were not reported. The pharmacist asked about a vaccine that her daughter received earlier this week and some problems she was having. The pharmacist mentioned that she (patient) complained severe like neck pain and headache on an unspecified date. So the pharmacist just needed to know if to seek medical attention or was this common. Pharmacist was requested to visit the nearest emergency room and call 911. The outcome of the event was unknown.
Information has been received from a physician concerning a 25 year old female pt who on 2/3/93, 3/10/93 and 9/10/93 was vaccinated IM with the 1st, 2nd and 3rd doses of Hep-B. The pt had a reactive anti-HBc in December and April, 2000. It was noted that the pt is asymptomatic. No further information is available.
This spontaneous report was received from a medical assistant refers to multiple unspecified patients of unknown gender and age. Information regarding patients' medical history, current conditions and concomitant medications were not provided. On unknown dates, the patients were vaccinated with improperly stored VAQTA (lot # L015460, expiry date: 20-JUL-2017). Medical assistant reported that the vaccine underwent temperature excursion at 50 degree Fahrenheit for 14 hours. There were no previous temperature excursion. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Breakthrough infection of COVID-19 - began with sore throat (day 1), muscle aches, congestion (started day 4), chest pressure, short of breath, oximeter's lowest point was 94 (days 5-8), then my congestion improved, muscle aches were replaced by fatigue, throat improved, just chest pressure (days 8-14).
Thirteen days after receiving the Vaccine I developed redness in a circular form around the injection site. The circle was about two to three  inches in diameter. There was no itching or swelling but warmth that brought my attention to look at it. As noted I have an allergy to Thimerisol and this reminded me of past FLU vaccines that I had received before I knew I was allergic to that Preservative. It has not been 24 hours since I noticed the event; I do not believe medical attention is warranted @ this time.
Zostovax was administered at approx. 1:30 pm on 07/03/2008.  Client states that by early evening on 07/03/2008, she was experiencing left sided facial numbness from left eye, to cheek, to nose, all of maxillary area and base of tongue. These symptoms were only on left side.  Client states that the symptoms persisted all Thursday evening and all day Friday (07/04/2008) and then gradually subsided.  Client called the Public Health Office on 07/07/2008 to report reaction.
On 7/19/00, my daughter had a very high fever (appox. 103F), lasting 3-4 days. She also, had a rash of dry and hard bumps. Visited doctor because of high fever on 7/20/00, stomach virus ruled out. She also, had a reduced appetite and very out of it watery eyes.
Pharmacist reports that the patient, who received her third lifetime dose of PNEUMOVAX on 27November2012, returned to the pharmacy on 29Nov2012 complaining of rash and warmth at the injection site and of "fatigue and not feeling well." No further information is available. Not recovered. Additional information is expected.
Body rash resembling Measles. Began on trunk and has spread to limbs and face. Treating with antihistamines.
I received my booster shot and afterwards I was experiencing the trouble with my vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient received bnt162b2 (BNT162B2), administration date 25Mar2022 (Lot number: FK9893, Expiration Date: May2022) at the age of 23 years as dose number unknown (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VYVANSE; DEXTROAMPHETAMINE [DEXAMFETAMINE SULFATE]; NIKKI taken for contraception. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: VISUAL IMPAIRMENT (non-serious) with onset 25Mar2022, outcome "unknown", described as "I received my booster shot and afterwards I was experiencing the trouble with my vision". Therapeutic measures were not taken as a result of visual impairment.  Additional Information: Other medication: Consumer stated, I also take a birth control and took actually before I went, I took like an allergy medicines. I took Vyvanse, Dextroamphetamine and the birth control daily and then today I took an allergy medication."  No follow-up attempts are possible. No further information is expected.
shingles; VERY PAINFUL; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had the first shot and still got shingles. The patient did not wish it on anyone. It was very painful. Now the patient had the second shot, hope patient did not get them again. The follow up was not required.
patient received the vaccine on March 20th, instantly felt sick, developed a fever.  Never fully felt " Well".  On March 27th her boyfriend discovered her unresponsive from Cardiac arrest, she has been on life support since.  They are pulling the plug today.
She woke up out of sleep with myalgias, rigors, fever and sore throat which lasted approximately 20 hours before decreasing.   She had acetaminophen every 4 hours which only partially helped.
COVID-19 pneumonia; too sick; pneumonia-related cough; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 PNEUMONIA (COVID-19 pneumonia) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced COVID-19 PNEUMONIA (COVID-19 pneumonia) (seriousness criterion medically significant). In September 2021, the patient experienced ILLNESS (too sick) and COUGH (pneumonia-related cough). The patient was treated with CODEINE for Cough, at an unspecified dose and frequency. At the time of the report, COVID-19 PNEUMONIA (COVID-19 pneumonia), ILLNESS (too sick) and COUGH (pneumonia-related cough) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was treated with unspecified steroid medications for pneumonia related cough. No concomitant medications were reported. The patient was concerned about the possibility of the vaccine being the cause of testing positive for COVID19  Company comment: This case concerns a 36-year-old female patient with no relevant medical history, who experienced the unexpected events of COVID-19 pneumonia. The event occurred approximately 8 days after the second dose of mRNA-1273. The rechallenge was not applicable, as the event happened after the first dose. The event was downgrade to non-serious due the patient was not hospitalized or meet the criteria for seriousness. The benefit-risk relationship of S mRNA-1273 in not affected by this report.; Sender's Comments: This case concerns a 36-year-old female patient with no relevant medical history, who experienced the unexpected events of COVID-19 pneumonia. The event occurred approximately 8 days after the second dose of mRNA-1273. The rechallenge was not applicable, as the event happened after the first dose. The event was downgrade to non-serious due the patient was not hospitalized or meet the criteria for seriousness. The benefit-risk relationship of S mRNA-1273 in not affected by this report.
Just a little pain; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 14 year-old male patient received bnt162b2 (BNT162B2), administration date 11Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "unknown", described as "Just a little pain". Additional information: Reporter had two male patients yesterday (21Feb2021) that asked for a booster [Pfizer BioNTech Covid-19 Vaccine]. 14 years old and 15 years old. Their last doses were given in the summer. Their mother was telling that they were given in Aug2021. She gave them the booster, 0.3mL, to both. The LOT number was FK9896. She made a mistake and did not ask for their vaccination cards until after and saw that their first dose was 11Aug2021 and their second dose was 12Oct2021. She was counting the interval between their last dose and the booster, and it was 19 days short of five months. They did very good with the first two doses. Just a little pain. So, she was hoping they do okay with the booster even though they got it early. Reporter have one or two patients to whom the first dose was given and didn't come to get their second dose for a month or two after the first dose, but reporter went ahead and gave the second dose. Some had diarrhea and vomiting after eating something, but it was not related to the vaccine. Two patient's reporter before had a big interval before the second dose. Reporter also asking, the booster dose was 0.3 (mL) Or was it 0.5, and thought it was 0.5mL for adults.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200317235 same reporter/different patient/same AE.
Had vaginal bleeding with clots after first dose of vaccine and for the month in between the 1st and 2nd doses of COVID vaccine, had irregular menstrual bleeding
J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/27/2023 FAILURE TO THRIVE SYNDROME, ADULT
Severe pain in (L) arm, could not move arm or touch deltoid x 4-5 days. S/p 2 weeks much better although still tender to palpation. Full range of motion available currently.
J96.00 ACUTE RESPIRATORY FAILURE 8/2/2023 ACUTE RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/2/2023 ACUTE RESPIRATORY FAILURE J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 8/17/2023 ACUTE RESPIRATORY FAILURE
Arm was sore for four days following injection, starting in the middle of the night.  Slight bump in muscle around injection site, but not otherwise inflamed looking
Few seconds after injection the patient experienced a moderate Hypotensive reaction which included LOC for about a minute. immediate treatment involved Lying the  patient in bed and elevated legs. Other patient symptoms included dizziness, facial pallor, auditory disturbances, cold extremities, weakness, light headedness and auditory disturbances. Patient was provided with oral electrolytes and a salty snack.  Patient remained in the facility until all symptoms were resolved. Before Injection patient had completed donating Plasma.
Patient noted they had 'every symptom expected including nausea'; This is a spontaneous report from a non-contactable consumer (patient reporting for herself). An adult female patient of unspecified age received a dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Not available/provided to reporter at the time of report completion), via an unspecified route of administration on Feb2021 at single dose for covid-19 immunization. It was unknown if the patient is pregnant at the time of vaccination. The patient was vaccinated at School/ Student Health Clinic. It was also unknown if the patient was diagnosed with COVID-19 with prior to vaccination; if been tested for COVID-19 since the vaccination; if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history and concomitant medications were not reported. The patient noted they had 'every symptom expected including nausea' on Feb2021. It was unknown if treatment was received for the adverse event. The outcome of the event was unknown. The case was considered as non-serious.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
the 14 year old patient was inadvertently administered a dose of PROQUAD; This spontaneous report was received from a physician assistant referring to a 14-year-old patient of unknown gender. The patient's pertinent medical history, concomitant drugs and drug allergies were not reported.   On 04-DEC-2019, the patient was inadvertently administered a dose of with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD), ( dose, strength, frequency, route, lot number and expiration date were not reported) for prophylaxis.
Fever; chills; body aches; joint pain; headache; severe fatigue; This is a spontaneous report from a contactable nurse (the patient).  A non-pregnant 55-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration, in the right arm on 22Feb2021 at 16:15 PM (at the age of 55 years) as a single dose for COVID-19 immunization. Medical history included hypertension. There was no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19 Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), in the right arm on 28Jan2021 at 4:15 PM. On 23Feb2021, about 18 hours after vaccination, the patient experienced fever, chills, body aches, joint pain, headache, severe fatigue. Events reported as non-serious. No treatment was given for the events. The clinical outcome of  the events fever, chills, body aches, joint pain, headache, severe fatigue was recovered. . It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Vertigo whenever I stood up/walked somewhere. It was less noticeable the next day.
PT 6.5 CM RED AREA AT SITE OF TDap no fever. Rx for Benadryl f/u on 11/17/16.
Child received DTaP, IPV in left deltoid 8/17 and MMR in right deltoid in early pm. Child developed a fever 103 degrees on 8/18/04 (3AM), swollen, hard, red, warm 3" around injection sites. On day of report to Health Dept, size remains the same. Hurts when touched, does not hurt to use it. Arm got better every day per PC to parent 8/24.